Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Magnetic resonance imaging (MRI) scanners have been used since the 1980s to take detailed images inside the body – helping doctors to make a medical diagnosis and investigate the staging of a disease.
An international team of researchers, led by Dr Munitta Muthana from the University of Sheffield’s Department of Oncology, have now found MRI scanners can non-invasively steer cells, which have been injected with tiny super-paramagnetic iron oxide nanoparticles (SPIOs), to both primary and secondary tumour sites within the body.
This targeted approach is extremely beneficial for patients as it dramatically increases the efficiency of treatment and drug doses could potentially be reduced – helping to alleviate side effects.
Revolutionary cell-based therapies, which exploit modified human cells to treat diseases such as cancer, have advanced greatly over recent years. However, targeted application of cell-based therapy in specific tissues, such as those lying deep in the body where injection is not possible, has remained problematic.
The new research suggests MRI scanners are the key to administering treatments directly to both primary and secondary tumours wherever they are located in the body.
The study, published today (date) in Nature Communications shows that cancer mouse models injected with immune cells carrying SPIOs and armed with the cancer killing oncolytic virus (OV) which infects and kills cancer cells, showed an 800 per cent increase in the effects of the therapy.
Dr Munitta Muthana, from the University of Sheffield, said: “Our results suggest that it is possible to use a standard MRI scanner to naturally deliver cell-based therapies to both primary and secondary tumours which would normally be impossible to reach by injection.
“This not only increases the therapeutic efficacy but also decreases the risk of unwanted side effects.
“The beauty of using the MRI scanner to administer the therapy is that you can also use it for its original purpose providing a real-time image-guide to ensure the treatment has gone where it is needed.”
The Latest on: Tumour busting therapies
via Google News
The Latest on: Tumour busting therapies
- Year in Review: From capital markets to CRISPR, 2019 a pretty good year for biopharmaon December 30, 2019 at 3:59 pm
Meanwhile, scientific breakthroughs led the way as cell and gene therapies gained ground, the first signs of success emerged with ... here’s quick look back at some of the top trends and news stories ...
- From cancer to stroke, the past ten years have seen astounding advances in medical scienceon December 30, 2019 at 2:01 pm
Breakthrough cancer therapies, life-saving stroke procedures and ‘rebooted’ donor hearts ... As they weren’t sure when exactly I’d had the stroke, they couldn’t offer me clot-busting drugs, as these ...
- Why Hasn’t Immunotherapy Been Working For Prostate Cancer? Bone Tumors May Be The Answeron November 16, 2019 at 9:22 am
Getty Immunotherapy drugs called immune checkpoint inhibitors have revolutionized therapy for several ... how the metastatic prostate tumors destroy bone, unleashing a protein called TGF-Beta (β), ...
- New evolution-busting drug overcomes resistance in aggressive breast cancerson October 4, 2019 at 4:07 pm
BOS172722 is an example of one of the new evolution-busting therapies that will be the focus of the ICR’s planned £75 million Centre for Cancer Drug Discovery. The centre is a £75m project – and we ...
- New evolution-busting drug overcomes resistance in aggressive breast cancerson October 4, 2019 at 4:01 pm
BOS172722 is an example of one of the new evolution-busting therapies that will be the focus of the ICR's planned £75 million Centre for Cancer Drug Discovery. The drug was discovered at the ICR in ...
- Immunotherapy patents: Why CAR-T is driving up patent activityon September 17, 2019 at 8:10 am
Patents for new cancer-busting immunotherapy treatments are some of the hottest ... The worldwide market for CAR-T therapies is expected to top $3 billion by 2025 according to reports by ...
- Applying 'rock-paper-scissors' gene circuits to cancer therapyon September 5, 2019 at 11:03 am
That allows for efficient delivery of cancer combination therapies, the researchers reported in the journal ... We’ve shown that it’s possible to keep circuit-busting mutations at bay. We found a way ...
- MRI scanner steers cancer-killing virus inside the bodyon August 17, 2019 at 5:00 pm
MRI scanners, normally used to take detailed images inside the body, can noninvasively steer tumor-busting therapies to target sites. Cell-based therapies, which exploit modified human cells to treat ...
- Busting Common Myths About Radiation Therapyon July 24, 2019 at 3:43 am
Radiation therapy is used in treatment for different types of cancers. It involves the use of high doses of radiation to destroy cancer cells thereby shrinking tumors. Treatment outcomes are likely to ...
- All the ASCO skinny: Lynparza's pancreatic win, Amgen's KRAS spotlight, Merck's history-busting and moreon June 3, 2019 at 7:51 am
In a phase 3 trial of certain premenopausal women with HR-positive, HER-2 negative breast cancer, combining Kisqali with hormone therapy cut the risk of death by 29% compared with endocrine therapy ...
via Bing News